Navigation Links
AMPAC Fine Chemicals Announces the Inauguration of the New cGMP Continuous Processing Development Facility
Date:3/9/2009

LAS VEGAS, March 9 /PRNewswire-FirstCall/ -- American Pacific Corporation (Nasdaq: APFC) is pleased to announce that its wholly-owned subsidiary, AMPAC Fine Chemicals LLC (AFC), located near Sacramento California, recently inaugurated a new kilogram scale cGMP Batch/Continuous Processing Development facility. The new facility can accommodate either batch reactors (20 to 50 liters) or AFC's continuous "zone reactor" technology using up to 7 reactors from 0.25 to 1 liter in volume.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090309/LA81048)

This new facility allows AFC to expand its scale-up capabilities. It will also be very useful in the demonstration of continuous reaction performance (throughput, yield and purity) using AFC's "zone-reactor" concept at significant scale (0.25 to 1 liter reactors). The new facility comprises two large walk-in hoods, a separate room for solid isolation using two dryers and two remote bays for handling energetic reactions.

Dr. Aslam Malik, President of AMPAC Fine Chemicals LLC, said "We are excited by the opening of this new facility. Through our history of handling energetic chemistry and highly potent compounds, AFC has developed an extensive knowledge and expertise in continuous processing. Smaller reactor volumes, smaller quantities of reactants, better yield and cleaner impurity profiles make the process safer, more reliable, and more economical than the traditional batch process. In an industry that has been traditionally batch, implementing continuous processing is not easy. However, due to the recent push by the FDA for Quality by Design and use of Process Analytical Technology, continuous processing is achieving greater acceptance in the pharmaceutical industry."

ABOUT AMPAC FINE CHEMICALS LLC

AFC is a U.S. based company with demonstrated capabilities in process development, scale-up, and cGMP-compliant commercial production of active pharmaceutical ingredients (API's) and registered intermediates for pharmaceutical and biotechnology customers. Its specially engineered facilities and experienced staff allow AFC to safely produce highly energetic compounds at commercial scale. In addition, AFC's other technology platforms include production of highly potent compounds, continuous processes and industrial-scale chromatographic separation using simulated moving bed chromatography (SMB).

ABOUT AMERICAN PACIFIC CORPORATION

American Pacific Corporation (AMPAC) is a leading custom manufacturer of fine chemicals, specialty chemicals and propulsion products within its focused markets. We supply active pharmaceutical ingredients and advanced intermediates to the pharmaceutical industry. For the aerospace and defense industry we provide specialty chemicals used in solid rocket motors for space launch and military missiles. AMPAC also designs and manufactures liquid propulsion systems, valves and structures for space and missile defense applications. We produce clean agent chemicals for the fire protection industry, as well as electro-chemical equipment for the water treatment industry. Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals. Additional information about us can be obtained by visiting our web site at www.apfc.com.


'/>"/>
SOURCE American Pacific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
2. Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase
3. Sigma-Aldrich to Present at the 19th Annual Citi Chemicals Conference Tuesday, December 2, 2008
4. Detecting dangerous chemicals with lasers, exploring the brains circuitry with light and more
5. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
6. NIH collaborates with EPA to improve the safety testing of chemicals
7. ADM Forms Industrial Chemicals Group
8. Nile Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results and Announces Conference Call on March 10, 2009
9. Cell Therapeutics Announces Receipt of NASDAQ Listing Update
10. Canadian Government Announces Funding for Leading Biotechnology Firms Project
11. InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences , ... life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer ... “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... line of medical marijuana products targeting the needs of consumers who are incorporating ... Kindred takes place in Phoenix, Arizona. , As operators of two successful Valley ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):